Beta
14879

Efficacy of Intravenous Vitamin-D Selective Receptor Activator (Paricalcitol) In Management of Secondary Hyperparathyroidism in Hemodialysis Patients, Single Center Experience

Article

Last updated: 03 Jan 2025